South Korea · Delayed Price · Currency is KRW ImmuneOncia Therapeutics Statistics
Total Valuation
KOSDAQ:424870 has a market cap or net worth of KRW 263.97 billion. The enterprise value is 170.84 billion.
| Market Cap | 263.97B |
| Enterprise Value | 170.84B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:424870 has 91.34 million shares outstanding. The number of shares has increased by 21.39% in one year.
| Current Share Class | 91.34M |
| Shares Outstanding | 91.34M |
| Shares Change (YoY) | +21.39% |
| Shares Change (QoQ) | +9.43% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | n/a |
| Float | 34.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.63 |
| P/TBV Ratio | 2.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.02, with a Debt / Equity ratio of 0.00.
| Current Ratio | 22.02 |
| Quick Ratio | 20.73 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | -7,072.59 |
Financial Efficiency
Return on equity (ROE) is -39.66% and return on invested capital (ROIC) is -25.51%.
| Return on Equity (ROE) | -39.66% |
| Return on Assets (ROA) | -24.03% |
| Return on Invested Capital (ROIC) | -25.51% |
| Return on Capital Employed (ROCE) | -29.99% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.21% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -48.21% |
| 50-Day Moving Average | 3,054.10 |
| 200-Day Moving Average | 7,181.65 |
| Relative Strength Index (RSI) | 43.34 |
| Average Volume (20 Days) | 171,045 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -14.38M |
| Operating Income | -30.19B |
| Pretax Income | -29.31B |
| Net Income | -29.31B |
| EBITDA | -29.34B |
| EBIT | -30.19B |
| Earnings Per Share (EPS) | -385.56 |
Balance Sheet
The company has 93.17 billion in cash and 41.65 million in debt, with a net cash position of 93.13 billion or 1,019.60 per share.
| Cash & Cash Equivalents | 93.17B |
| Total Debt | 41.65M |
| Net Cash | 93.13B |
| Net Cash Per Share | 1,019.60 |
| Equity (Book Value) | 100.28B |
| Book Value Per Share | 1,233.61 |
| Working Capital | 94.61B |
Cash Flow
In the last 12 months, operating cash flow was -26.30 billion and capital expenditures -375.15 million, giving a free cash flow of -26.68 billion.
| Operating Cash Flow | -26.30B |
| Capital Expenditures | -375.15M |
| Depreciation & Amortization | 845.07M |
| Net Borrowing | -54.16M |
| Free Cash Flow | -26.68B |
| FCF Per Share | -292.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:424870 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.39% |
| Shareholder Yield | -21.39% |
| Earnings Yield | -11.10% |
| FCF Yield | -10.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KOSDAQ:424870 has an Altman Z-Score of 66.39 and a Piotroski F-Score of 2.
| Altman Z-Score | 66.39 |
| Piotroski F-Score | 2 |